SITC Cancer Immunotherapy CONNECT

SITC Fellowships

Apply for research funding!

Deadline extended until April 17, 2023

The SITC Forward Fund is pleased to offer six SITC Fellowships totaling $640,000 in funding. Get started on your application now! Submissions are due by April 17, 2023.

Learn More and Apply

Sparkathon 2023.png

Apply for Sparkathon 2023

Applications due by 5 p.m. PST on April 18, 2023

Network within the cancer immunotherapy field and hear the latest research in a synergistic environment amongst peers and experts in the field.

Learn More

SITC WIN LI 2023

Register Today for WIN LI

Sept. 28-29, 2023 in Chicago OR Aug. 9-10, 2023 Virtual
The Women in Cancer Immunotherapy Network (WIN) is a SITC initiative to promote and elevate women in the cancer immunotherapy field.
Applications are due by April 11, 2023, at 5 P.M. PST

Learn More

Winter School

A Focus on Lung Cancers

Join your colleagues in sunny San Diego for an in-depth, clinical education program focused on Lung Cancers – Thursday, April 6, 2023 (San Diego and Live Via Zoom Webinar).

Register Today

SITC CIG App Homescreen Cropped

Download the new SITC Clinical Practice Guidelines Mobile App!
The first and only immunotherapy-specific clinical practice guidelines app featuring expert panel recommendations. Available for FREE for iOS and Android.

Download Now

Immunoprevention.png

SITC Immunoprevention Virtual Summit

Join us Monday, April 3, for this open-door educational event. The summit is a free, public event that features expert panel discussions, invited speakers, and attendee question and answer periods.

Register Today

New SITC Clinical Practice Guidelines Published

Includes Acute Leukemia, Breast Cancer, Hepatocellular Carcinoma, Immune Checkpoint Inhibitor-related Adverse Events, Urothelial Cancer, & Nonmelanoma Skin Cancer. Free companion educational webinars available.

Learn more

JITC Anniversary

Celebrate a Decade of Publishing with SITC’s Official Journal

Hear from editors about the state of the field, explore the journal’s major milestones, and read top content.

LET'S CELEBRATE!

JITC Anniversary

Perspectives on Immunotherapy for Early-Stage Tumors

Understand the role of immunotherapy for the management of early-stage solid tumors and care for patients with these cancer types in clinical practice. Earn CME/ABIM MOC credits.

View Activity

Immunotherapy

Advances in Cancer Immunotherapy™: A Focus on Genitourinary Cancers

Wednesday, March 22, 2023 | 1-5 P.M. EDT | Live via Zoom Webinar

Join a panel of experts for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for genitourinary cancers.

Learn More
Immunotherapy

Advances in Cancer Immunotherapy™: A Focus on Lung Cancer

Thursday, April 6, 2023 | 12-4 P.M. PDT | Virtual & San Diego, CA

Join a panel of experts for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for lung cancer.

Learn More
Immunotherapy

Advances in Cancer Immunotherapy™: A Focus on Head & Neck Cancers

Tuesday, April 11, 2023 | 1-5 P.M. EDT | Live via Zoom Webinar

Join a panel of experts for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for head & neck cancers.

Learn More
Immunotherapy

Advances in Cancer Immunotherapy™: A Focus on Toxicity Management
- Part 1

Monday, April 24, 2023 | 12-4 P.M. CDT | Virtual & Chicago, IL

Join a panel of experts for an afternoon of in-depth education on all aspects of toxicity management.

Learn More
Immunotherapy

Advances in Cancer Immunotherapy™: A Focus on Pediatric Cancers

Wednesday, May 3, 2023 | 9 A.M. - 1 P.M. EDT | Live via Zoom Webinar

Join a panel of experts for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for pediatric cancers.

Learn More
icon-patients.png

For patients

Explore comprehensive resources and educational opportunities for cancer patients and those who advocate for them.

Explore

icon-stethoscope.png

For Clinicians

Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.


Explore

icon-researcher.png

For Researchers

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.


Explore

Latest Discussions

  • Hi there, I am pleased to inform you about Advances in Cancer Immunotherapy (ACI): A Focus on Nurses, an educational program providing the latest immuno-oncology education specific to nurses. A Focus on Nurses takes place on Wednesday, May 17 and ...

  • Join a diverse group of experts and thought leaders in the fields of HCT, cellular therapies, and related medical subspecialties for the 3rd International Toxicities Symposium. Speakers will discuss current advances in the field, mechanisms of toxicities, ...

  • Hi there! I am pleased to inform you about Advances in Cancer Immunotherapy (ACI), an educational series providing focused clinical training on a specific disease state or topic. These innovative half-day programs offer in-depth instruction on ...

icon-twitter.png

Follow the SITC Twitter Feed.

Connect with colleagues at these Upcoming Events.


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders
seeking toadvance research in the cancer immunotherapy field.

Learn More

The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More

 

Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

 

Learn More